Liu Song Yin
Directeur Général chez Sunho Biologics, Inc.
Profil
Liu Song Yin is currently the CEO, Executive Director & Chief Scientific Officer at Sunho Biologics, Inc. and the Chief Executive & Scientific Officer at SunHo (China) Biopharmaceutical Co. Ltd.
He previously worked as an Executive Director at Genscript Biotech Corp.
Dr. Yin received his undergraduate degree from the University of Science & Technology of China in 2008.
Postes actifs de Liu Song Yin
| Sociétés | Poste | Début |
|---|---|---|
Sunho Biologics, Inc.
 Sunho Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Sunho Biologics, Inc. is a biopharmaceutical company engages in the development and commercialization of biologics that regulate immune microenvironment by directly modulating both the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou City, China. | Directeur Général | 21/07/2023 |
| SunHo (China) Biopharmaceutical Co. Ltd. | Directeur Général | 01/11/2020 |
Anciens postes connus de Liu Song Yin
| Sociétés | Poste | Fin |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Directeur/Membre du Conseil | 01/10/2020 |
Formation de Liu Song Yin
| University of Science & Technology of China | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sunho Biologics, Inc.
Sunho Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Sunho Biologics, Inc. is a biopharmaceutical company engages in the development and commercialization of biologics that regulate immune microenvironment by directly modulating both the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou City, China. | Commercial Services |
| SunHo (China) Biopharmaceutical Co. Ltd. |